Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis

• Main Authors: Changchun Hou MD (Author), Xinxin Hao PhD (Author), Ning Sun MD (Author), Xiaolin Luo MD (Author), Zhichun Gao MD (Author), Ling Chen MD (Author), Xi Liu MD (Author), Zhexue Qin MD (Author)
• Format: Book
• Published: SAGE Publishing, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Backgrounds: Our study aimed to identify and predict patients with heart failure (HF) taking novel-dose Sacubitril/Valsartan (S/V) at risk for all-cause readmission, as well as investigate the possible role of left ventricular reverse remodeling (LVRR). Methods and results: There were 464 patients r...